Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kilroy Realty ( (KRC) ) has shared an announcement.
On February 9, 2026, Kilroy Realty reported that for the fourth quarter of 2025 it generated $272.2 million in revenue, with net income to common shareholders falling to $12.4 million and funds from operations (FFO) at $117.2 million, reflecting lower earnings versus the prior-year quarter. For full-year 2025, revenue slipped slightly to $1.11 billion and FFO declined, but net income rose to $276.1 million, underscoring a year of active portfolio management amid a challenging office backdrop.
Operationally, Kilroy’s stabilized portfolio was 81.6% occupied and 83.8% leased at year-end 2025, with about 2.1 million square feet of leases signed over the year, its strongest annual leasing since 2019 despite rent spreads declining on second-generation space. The company reported its best fourth-quarter leasing in six years, driven in part by demand for life science space at Kilroy Oyster Point Phase 2 in South San Francisco, where major tenants including the University of California, San Francisco and Acadia Pharmaceuticals contributed to the project reaching 44% leased, signaling traction in the life science segment.
Kilroy also executed significant capital recycling in 2025, selling multiple office assets and land parcels in Los Angeles, Silicon Valley, and San Diego while acquiring the Nautilus life science campus in Torrey Pines and Maple Plaza in Beverly Hills to tilt the portfolio toward stronger submarkets. On the balance sheet, the company refinanced upcoming maturities by issuing $400 million of 5.875% unsecured senior notes due 2035 and redeeming $400 million of 2025 notes, and it maintained shareholder returns with a quarterly dividend of $0.54 per share paid in January 2026, moves that collectively bolster liquidity and support its transition toward higher-growth, life science-weighted assets.
The most recent analyst rating on (KRC) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Kilroy Realty stock, see the KRC Stock Forecast page.
Spark’s Take on KRC Stock
According to Spark, TipRanks’ AI Analyst, KRC is a Outperform.
Kilroy Realty’s overall stock score reflects strong financial stability and positive earnings call highlights, particularly in leasing activity and strategic acquisitions. While technical indicators suggest short-term bearish trends, the company’s valuation and attractive dividend yield provide a solid investment case. The raised FFO guidance and strategic moves in high-demand sectors like tech and life sciences bolster the outlook, despite challenges in lease expirations.
To see Spark’s full report on KRC stock, click here.
More about Kilroy Realty
Kilroy Realty Corporation is a Los Angeles-based real estate investment trust focused on high-quality office and life science properties, primarily in West Coast innovation and life science hubs such as San Diego, Silicon Valley, and the San Francisco Bay Area. The company targets well-amenitized, institutional-grade assets and actively recycles capital through selective acquisitions, redevelopments, and dispositions to refine its portfolio mix and capture demand from technology, media, and biotech tenants.
Its strategy includes developing and repositioning campuses like Kilroy Oyster Point for life science users, expanding in supply-constrained submarkets such as Torrey Pines and Beverly Hills, and maintaining a stabilized portfolio while managing leverage through unsecured debt issuance and asset sales. This approach is designed to align the portfolio with evolving tenant preferences for modern, flexible, and amenity-rich space in leading coastal markets.
Average Trading Volume: 1,567,060
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.18B
For detailed information about KRC stock, go to TipRanks’ Stock Analysis page.